Fluticasone Propionate Multidose Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Inhaler

- Asthma
- Completed

Study Title: Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Teva Identifier: FSS-AS-30003 | 2016-003835-39

ClinicalTrials.gov Identifier: NCT02980133

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Fluticasone Propionate | Drug: Fluticasone Propionate/Salmeterol | Drug: Placebo MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 4 Years to 11 Years

Trial Duration: December 28, 2016 - April 13, 2019

Phase: Phase 3

Additional info

Synopsis

Study Type

Interventional